法医精神病患者失眠的治疗:一个随机对照试验
Maaike Marina Van Veen1, Gretha Johanna Boersma2, Julie Karsten3
1Centre of Expertise on Sleep and Psychiatry, GGZ Drenthe Mental Health Institute, 9404 LA Assen, The Netherlands.
Brain sciences
|March 28, 2025
概括
失眠的认知行为疗法 (CBT-I) 有效地减少了男性法医精神病患者的失眠和敌意. 这凸显了在这个人群中治疗失眠的重要性.
科学领域:
- 法医精神病学 法医精神病学
- 睡眠医学 睡眠医学
- 临床心理学 临床心理学
背景情况:
- 失眠在法医精神病患者中很普遍,影响心理健康,情绪调节和自我控制.
- 失眠与冲动性,敌意和侵略性有关,这些行为在法医环境中至关重要.
- 失眠的认知行为疗法 (CBT-I) 对这个患者群体来说是一个潜在的干预措施.
研究的目的:
- 评估CBT-I在改善睡眠和减少男性法医精神病患者心理病理,敌意,冲动和攻击性的有效性.
- 评估CBT-I对主观和客观睡眠指标的影响.
- 确定CBT-I是否可以减轻与失眠相关的行为问题.
主要方法:
- 一项为期14周的随机对照试验与31名男性法医精神病患者进行.
- 参与者被分配到CBT-I干预组或等候名单对照组.
- 测量结果包括自我报告的失眠,一般的精神病理,敌意,冲动性,侵略性和通过动画成像测量的睡眠效率.
主要成果:
- 与等待名单组相比,CBT-I组在自我报告的失眠症状和敌意方面表现出显著更大的减少.
- 在治疗后的一般精神病理,冲动性或攻击性方面,没有观察到群体之间的显著差异.
- 动图数据没有显示CBT-I和等候名单组之间的睡眠效率有显著差异.
结论:
- 在男性法医精神病患者中,CBT-I是治疗失眠症状和敌意的有效方法.
- 失眠治疗在法医精神科护理中至关重要,特别是因为它对敌意的积极影响.
- 进一步的研究可能会探索CBT-I对这一群体的侵略性和冲动性的更广泛影响.
相关概念视频
02:07Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.9K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.9K
01:26Psychosis: Goals of Pharmacotherapy
706
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
706
01:19Management of Insomnia
785
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
785
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
981
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
981
01:27Insomnia
620
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
620